학술논문

Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi
Document Type
Article
Source
In: Annals of Hematology. (Annals of Hematology, October 2021, 100(10):2547-2556)
Subject
Language
English
ISSN
14320584
09395555